AgeX Therapeutics predicts a \”revolution\” in aging over the next 10 years
AgeX Therapeutics Inc. (NYSEAMERICAN AGE) CEO Michael West sat with Proactive’s Christine Corrado during the Biotech Showcase in San Francisco. The Alameda biotechnology company in California is developing a treatment for metabolic disorders like Type 2 diabetes using cell therapy.
Source:
https://www.youtube.com/watch?v=qMGAane9QVc
